Introduction
============

Lactic acid bacteria (LAB) are Gram-positive, anaerobic or microaerophilic, non-sporulating microorganisms that inhabit diverse environments including milk and plant surfaces, as well as the mouth, gastrointestinal tract, and vaginal tract of humans and animals ([@B48]). Traditionally, they have been employed for food and dairy fermentations, but have more recently garnered attention for their health-promoting properties with many species used widely as probiotics ([@B39]; [@B38]). Recombinant LABs are frequently harnessed for mucosal delivery of biomolecules such as therapeutic proteins or vaccine antigens ([@B7]). In comparison to traditional intravenous or intramuscular vaccine administration, the mucosal route enables immunizations to be performed orally, reducing potential side effects while increasing specificity for chronic illnesses and infections associated with mucosal tissues ([@B10]; [@B81]). Furthermore, many LABs are bile and acid tolerant, act as natural adjuvants, and interact with cells of the immune system ([@B80]), making them ideal candidates for antigen carriage.

The LABs most frequently chosen for vaccine delivery are *Lactococcus lactis* and select species of the *Lactobacillus* genus ([@B80]; [@B10], [@B9]; [@B81]). However, unlike *L. lactis*, several species *Lactobacillus* have been shown to possess surface-layers (S-layers) ([@B29]). S-layers have been detected on both Gram-positive and Gram-negative bacteria and are nearly ubiquitous in archaea ([@B23]). They are defined as two-dimensional crystalline arrays composed of repeating proteinaceous subunits that constitute the outermost layer of a cell envelope ([@B23]). The S-layer proteins (Slps) attach to the underlying peptidoglycan via electrostatic interactions and possess inherent, entropy-driven affinities to self-assemble with each other ([@B29]). Thus far, S-layers have been characterized for their role in maintaining cell shape; acting as molecular sieves; serving as binding sites for large molecules, ions, or phages; and mediating surface adhesion ([@B71]). Additionally, Slps are some of the most abundant proteins synthesized by the cell, making them metabolically expensive but also underscoring their importance to the organism ([@B66]; [@B23]). Their high expression, periodicity, and self-assembling properties have made them a target for numerous applications in biotechnology and nanotechnology ([@B4]; [@B29]; [@B71]).

In the following review, we examine Slp applications in recombinant protein expression and biotherapeutic delivery via their distinct genetic building blocks: the strong native promoter, which can synthesize as many as 500 Slp subunits per second; the signal peptide, that can trigger robust secretion of target molecules; and the structural domains, which can be harnessed for both cell surface display of heterologous proteins or enhancement of host adhesion (**Figure [1A](#F1){ref-type="fig"}**). Despite the existence of several recombinant protein expression systems based on one or more components of the *Lactobacillus* S-layer, this area of research still remains largely underexploited. Thus, the purpose of this review is to not only shed light on past S-layer studies, but also to advocate for future utilization of Slps in mucosal vaccine and biotherapeutic delivery research.

![Simplified depiction of the genetic components comprising the Slp protein and how they can be harnessed for heterologous protein expression systems. **(A)** The genetic building blocks of an S-layer gene, including the promoter, secretion signal peptide, N-terminal self-assembly domain, and C-terminal peptidoglycan anchor. Each can be harnessed together or separately for antigen and biotherapeutic delivery applications. **(B)** The Slp promotor induces the production of high levels of target protein which will accumulate within the cytoplasm of the host bacterium. **(C)** The Slp secretion signal yields robust secretion of antigen into the extracellular environment. **(D)** Cell surface display of a foreign peptide can be achieved via fusion to an Slp anchoring domain (N- or C- depending on species). **(E)** The highest levels of antigen expression and cell surface display can be obtained via direct integration into the Slp, but epitope size is extremely limited in order to maintain array formation. **(F)** A novel display strategy utilizing S-layer associated protein (SLAP) fusions which theoretically enable the surface display of much larger proteins.](fmicb-09-02264-g001){#F1}

Harnessing the Strong Native Promoter
=====================================

The bacterial S-layer array is composed of an estimated 5 × 10^5^ subunits, representing 10--15% of the total protein content of the bacterium ([@B70]; [@B4]). During exponential growth phase, approximately 500 subunits per second must be synthesized, translocated to the cell surface, and incorporated into the existing lattice structure ([@B71]). In order to obtain these high levels of transcription, S-layer genes possess strong, efficient promoters, which can be harnessed for protein production systems (**Figure [1B](#F1){ref-type="fig"}**). Within the *Lactobacillus* genus, this research has predominately been limited to *slp* promoters of *Lactobacillus acidophilus* and *Lactobacillus brevis*.

Several studies have investigated the versatility of *Lactobacillus* S-layer promoters for driving heterologous protein expression in various LAB hosts. Lactobacilli regularly possess multiple *slp* genes within the same strain that are not all concurrently active ([@B29]). Although SlpA is the major constituent of the *L. acidophilus* S-layer, it can be moved to an inactive position triggering expression of the once silent SlpB ([@B12]; [@B42]). When the *L. acidophilus ATCC 4356 slpA* and *slpB* promoters were evaluated in *Lactobacillus casei* ATCC 393, only *slpA* remained active under all tested growth phases ([@B13]). However, the same *slpA* promoter, although highly efficient in *L. lactis*, was nearly inactive in isolates of *Lactobacillus reuteri* ([@B49]). The *L. acidophilus* NCFM *slpA* promoter was used to drive expression of a green fluorescent protein (GFP) in shuttle vectors based on *oriV1* and *oriV2* replicons ([@B16]). Similarly, the plasmids exhibited distinct properties based on which strain they were ported into as well as growth-phase-dependent effects. Both plasmids were capable of replicating in strains of *L. casei* and *Lactobacillus delbrueckii*, but only the *oriV1* plasmid, pEL5.6, could replicate in *Lactobacillus paracasei* ([@B16]). The functionality of the *L. brevis* ATCC 8287 *slpA* promoter was evaluated in three LAB hosts: *L. lactis* MG1614, *Lactobacillus plantarum* NCDO1193 and *Lactobacillus gasseri* NCK334, via the expression of various reporter genes ([@B34]). The S-layer promoter was recognized in each strain, but was particularly active in *L. lactis* and *L. plantarum.* In fact, aminopeptidase N (PepN) reporter activity within *L. plantarum* was 30-fold higher compared to the *Lactobacillus helveticus* PepN native host and composed a staggering 28% of the total cellular protein during late exponential growth phase. In summary, *Lactobacillus slp* promoters are effective tools for driving recombinant protein expression, but optimization based on host and growth conditions is essential.

The S-layer promoter has also been harnessed for reporter expression *in situ*. Plasmid instability and antibiotic markers can complicate the use of these constructs when moving into human clinical trials or to market, thus chromosomal insertions have gained immense popularity. For *L. acidophilus* NCFM, a pORI-based *upp* counterselective gene replacement system ([@B24]) has considerably aided this effort (see "Engineering Platforms"). Originally intended for knockout characterizations, it was first employed for a knock-in by cloning a β-glucuronidase (*gusA*) reporter downstream of the *slpA* gene ([@B21]). The resulting mutant exhibited a three log increase in GusA activity in comparison to the *gusA*-negative parent, and the study established a framework for the exploitation of highly expressed genomic regions for heterologous protein production ([@B21]). Although this particular system was never evaluated within the context of vaccine delivery, the technique was shown effective for expressing antigens using an alternative highly expressed region within the *L. acidophilus* genome ([@B60]).

Moving beyond reporter genes and targeting more specific therapeutics, the *L. brevis* JCM 1559 *slpA* promoter was evaluated in an *L. casei* IGM393 host via incorporation into a mouse interleukin 10 (IL-10) secretion system ([@B35]). Administration of IL-10 was previously shown to be an effective treatment of murine colitis when delivered via recombinant *L. lactis* ([@B76]). The authors sought to improve upon this design by substituting in a strain hypothesized to be better adapted to mammalian body temperature. The delivery system was successful in that it yielded high levels of IL-10 secretion when cloned into *L. casei*, but accumulation of the protein varied widely based on pH ([@B35]). Maximum efficiency occurred at pH 8.0 and dropped drastically as the pH became more acidic. Although the authors attributed low levels of the protein to its physical characteristics ([@B35]), the selection of a promoter from a free-living species (e.g., *L. brevis*) over a low pH tolerating, vertebrate-adapted organism (e.g., *L. acidophilus*), may have also contributed ([@B22]). Nonetheless, the S-layer promoter has repeatedly demonstrated its utility for driving protein production systems, and thus merits future research with a focus on therapeutic molecule delivery.

Exploitation of the Secretion Signal Peptide
============================================

All *Lactobacillus* S-layer proteins characterized thus far are preceded by a 25--32 amino acid signal peptide sequence indicative of secretion through the general secretory pathway ([@B29]). By cloning this short sequence upstream of an antigen or biotherapeutic molecule, one can obtain robust secretion of a target protein (**Figure [1C](#F1){ref-type="fig"}**), thus this peptide is frequently harnessed for biotechnological applications.

The *L. brevis* ATCC 8287 *slpA* signal sequence, along with the promoter and transcription terminator, were used to drive expression and secretion of the *Escherichia coli* β-lactamase (*bla*) reporter gene in *L. lactis*, *L. brevis*, *L. plantarum*, *L. gasseri*, and *L. casei*, using a low-copy-number plasmid derived from pGK12 ([@B67]). In all hosts tested, Bla was expressed and released into the culture medium, though highest yields were obtained by recombinant *L. lactis* and the strain of *L. brevis* from which the SlpA components were derived. Production of Bla was mainly restricted to exponential growth phase ([@B67]). Since the system was under control of an *slpA* promoter, it was unsurprising that efficiency was host-specific and growth-phase-dependent (see "Harnessing the strong native promoter").

The Slp secretion signal has frequently been harnessed for targeted therapeutic applications. In a study seeking to develop a recombinant *L. lactis* mucosal vaccine against porcine post-weaning diarrhea and edema disease, signal peptides from the *L. lactis* major extracellular protein, Usp45, and *L. brevis* SlpA, were used to stimulate the secretion of an *E. coli* F18 fimbrial adhesion protein (FedF) fused to a proteinase PrtP cell wall anchor ([@B47]). Both expression systems induced secretion of all tested FedF-PrtP fusions, however, the quantity of fusion proteins found in the culture medium was four to sixfold higher in those containing the SlpA signal peptide. This was a compelling find considering that the Usp45 signal sequence, previously shown to be one of the most effective *L. lactis* secretion signals ([@B59]), was outperformed by the heterologous SlpA signal sequence. A similar result was obtained with the human interferon alpha 2b (hIFNα-2b) gene ([@B82]), used worldwide for the treatment of diseases such as hepatitis B and C ([@B15]). The addition of the *L. brevis* SlpA signal peptide increased the secretion efficiency threefold in comparison to the lactococcal Usp45 signal sequence ([@B82]).

The SlpA signal sequence has also been employed for secretion of chromosomally inserted heterologous proteins. The *Bacillus anthracis* protective antigen (PA), fused to a dendritic cell (DC)-targeting peptide, was previously shown to induce protective immunity when delivered on a plasmid via *L. acidophilus* NCFM ([@B55]) and *L. gasseri* ([@B56]). Since a major advantage of using recombinant microbes for vaccine delivery is their ability to express multiple antigens ([@B80]), the *B. anthracis* PA was co-expressed with the *Clostridium botulinum* Serotype A neurotoxin heavy-chain antigen ([@B60]). The *C. botulinum* vaccine cassette, which utilizes an *L. acidophilus* SlpA secretion signal, was chromosomally inserted downstream of the highly expressed enolase gene. Western blot analysis and RNA sequencing confirmed expression of the two antigens ([@B60]). Although this strain was never evaluated *in vivo*, a similarly, constructed strain, also utilizing the SlpA secretion signal, but carrying only the *C. botulinum* antigen ([@B60]), was used to vaccinate mice but unable to confer complete protection ([@B64]). Rather, vaccine efficacy was enhanced by intradermal injection of the purified immunogenic subunit, which elicited robust memory B cell responses and rendered mice resistant to lethal doses of botulinum neurotoxin serotype A ([@B64]).

The Slp signal sequence is capable of stimulating ample secretion of target molecules, prompting its continued use in vaccine research platforms. Although antigen secretion by recombinant LABs has been shown effective for treating disease ([@B57], [@B55], [@B56]), exposure to proteolytic enzymes, low pH, and bile salts may encourage protein degradation and therefore decreased functionality ([@B80]); consequently cell wall anchoring has become a popular alternative. However, surface display is a balancing act. High exposure of a protein implies optimal host interaction, but also increased susceptibly to degradation. Alternatively, low exposure, via compact protein folding or embedment within the cell wall, confers protection in exchange for diminished efficacy ([@B53]). Several S-layer-mediated surface display approaches have attempted to resolve this relationship.

The Self-Assembling and Anchoring Domains of the Slp
====================================================

Cell wall anchoring via fusion to Slp structural domains (**Figure [1D](#F1){ref-type="fig"}**) enables direct interaction of target peptides with host mucosal tissues while simultaneously protecting them from degradation ([@B10]; [@B79]). The first S-layer-mediated display of a foreign epitope was generated by fusing the S-layer homology (SLH) domain of *B. anthracis* to the normally secreted levansucrase of *Bacillus subtilis* ([@B52]). The surface-exposed levansucrase retained its enzymatic and antigenic properties, prompting a new area of research which exploits the anchoring abilities of the Slp for cell surface presentation. *Lactobacillus* Slps do not possess SLH domains and are instead composed of two structural domains: a variable terminal for monomer self-assembly (N- or C- depending on the species), and a highly conserved peptidoglycan anchor ([@B73]; [@B29]).

Several studies have used S-layer-mediated anchoring for recombinant protein display on S-layer-deficient bacteria. The cell wall binding domain of the *L. crispatus* F5.7 Slp (LbsA) in conjunction with the Slp promoter and secretion signal, were used for surface display of a GFP on several *Lactobacillus* chicken isolates ([@B58]). The intention was to generate a vaccine delivery framework for the immunization of broilers against infectious diseases, but never evolved past proof of concept. Vaccination via recombinant bacteria is a particularly attractive option for livestock and poultry operations since the lyophilized microorganisms can be blended into feed; a process that is easily scaled up ([@B79]). For human applications, the complete SlpA from *L. acidophilus* ATCC 4356 was fused to a GFP reporter for external presentation on a plasmid-cured, lactose-deficient derivative of *L. casei* ATCC 334 ([@B63]). The authors were able to develop a food-grade cell surface display vector by substituting lactose metabolism genes in place of antibiotic selection markers and verified gastrointestinal stability via *in vitro* modeling ([@B63]). The *L. crispatus* K2-4-3 SlpB C-terminal domain, LcsB, was employed for the display of not only a GFP reporter ([@B27]), but also a carcinoembryonic antigen (CEA) ([@B83]). Previous studies have shown that CEA is capable of eliciting strong T-cell and humoral immune responses, which can hinder tumor growth ([@B25]). Oral administration of recombinant CEA-presenting *L. lactis* to mice yielded significantly higher levels of CEA-specific secretory IgA and a higher spleen index in comparison to CEA antigen alone or the negative control, demonstrating the potential of *L. lactis* CEA as a cancer vaccine ([@B25]).

Since the S-layer of *L. crispatus* is capable of binding intestinal extracellular matrices such as collagen and laminin, heterologous expression of Slps has also been used to improve the adhesive capacity of host organisms. For example, the *L. crispatus* JCM5810 collagen-binding S-layer protein, CbsA ([@B51]), as well as its individual domains ([@B1]), were expressed on the surface of *L. casei* enabling recombinant organisms to bind various extracellular matrices. Similarly, a surface display cassette consisting of the *L. brevis* ATCC 8287 SlpA receptor-binding domain fused to a PrtP spacer enhanced *L. lactis* adherence to Intestine 407 cells ([@B3]). Both approaches were able to significantly increase the adhesive capacity of engineered organisms, but yet to be evaluated is the probable synergistic effect of combining improved adhesion with an S-layer anchored antigen in what could potentially be a potent vaccine design platform.

Unlike much of the work presented in this review, a handful of studies achieved Slp-mediated display of foreign proteins without DNA manipulation in the host by exploiting the inherent ability of Slps to anchor and self-assemble. For instance, the *L. acidophilus* C-terminal anchor (SAC) was attached to a GFP reporter, then produced and purified in *E. coli*. The SAC-GFP fusion protein was capable of binding lithium chloride-pretreated surfaces of wild-type *L. acidophilus*, *L. helveticus*, and *L. crispatus* ([@B73]). Similarly, *L. crispatus* K2-4-3 LcsB-GFP fusions were able to associate with SDS-pretreated surfaces of various S-layer-forming LABs including *L. brevis*, *L. helveticus*, *L. crispatus*, and *Lactobacillus salivarius* as well as several non-S-layer-formers, including *L. lactis, L. delbrueckii*, *Lactobacillus johnsonii*, and *Streptococcus thermophilus* ([@B27]). Interestingly, neither the SAC-GFP fusion nor LcsB-GFP were able to bind the surface of *L. casei* ([@B73]; [@B27]). This approach is unique in that it offers an alternative way to deliver foreign proteins while also circumventing the GMO (genetically modified organism) label, but is limited by its inability to generate additional heterologous protein *in vivo* and susceptibility to replacement by wild type Slps. However, in general, studies using heterologously expressed Slps and Slp anchors are hindered by inadequate secretion across the cell wall ([@B27]) or inability to form an array due to irregular folding and/or lack of cell surface exposure ([@B51]). Consequently, rather than tease apart the efficient Slp secretion and display system, there is now interest in harnessing it as a whole through the direct insertion of foreign peptides within the context of the protein.

Delivery Via Direct Integration Within the Slp
==============================================

The extraordinarily high, stable abundance of the Slp, makes it an enticing target for antigen display and delivery via direct integration into its genome sequence (**Figure [1E](#F1){ref-type="fig"}**). The presentation of an exogenous protein within the context of the Slp was first achieved in *Caulobacter crescentus* through the random introduction of a pilin peptide from *Pseudomonas aeruginosa* strain K. Eleven potential sites of successful insertion were identified, demonstrating for the first time the capacity of the Slp to act as a carrier for foreign epitopes ([@B11]).

Many subsequent studies have focused on mapping the S-layer to gain insight into ideal positioning for novel insertions, including in *Lactobacillus*. In *L. acidophilus* ATCC 4356, peptides ranging from 7 to 13 amino acids were randomly introduced into the Slp ([@B72]). Within the variable N-terminal (SAN), five of these positions maintained paracrystalline structure formation *in vitro*, while four others resulted in the complete abolishment of any array-forming capacity. Unsurprisingly, an insertion into the cell wall-binding domain had no effect on assembly ([@B72]). Similarly, the *L. brevis* SlpA was mapped via cysteine-scanning mutagenesis combined with sulfhydryl modification to identify locations of high surface accessibility and verify that the mutations did not alter self-assembly properties ([@B78]). Combined, these works established several stable, surface-accessible insertion sites within the *Lactobacillus* Slp, yet few researchers have capitalized on this knowledge.

Currently, only two studies have successfully integrated antigens within the context of the *Lactobacillus* Slp. Through an inducible expression system, the poliovirus VP1 epitope was evaluated in four potential *L. brevis* ATCC 8287 *slpA* insertion sites ([@B2]). The location that demonstrated the best surface expression was then targeted for chromosomal insertion of the c-Myc epitope via direct double-crossover integration ([@B2]). A uniformly chimeric S-layer was obtained without any effect on array formation. More recently, the membrane proximal external region (MPER) epitope from human immunodeficiency virus type 1 (HIV-1) was inserted into *L. acidophilus* NCFM SlpA ([@B37]). *L. acidophilus* NCFM is regularly employed for mucosal vaccine delivery due in part to its direct interactions with the dendritic cell-specific antigen DC-SIGN ([@B42]) and adaptation to the harsh conditions associated with gastric transit ([@B65]). Vaccination via the recombinant organism, in conjunction with an IL-1β adjuvant, successfully stimulated MPER-specific antibody production in both the serum and mucosal secretions of mice ([@B37]). This study marks the first and only instance of an Slp-integrated antigen being evaluated *in vivo*.

The establishment of a uniformly chimeric S-layer translates to approximately 10^5^ instances of epitope display on the surface of a single bacterium ([@B70]). Despite these considerable numbers, insert size is exceptionally limited in order to preserve S-layer array formation ([@B72]). Currently, peptides longer than 19 amino acids are unable to be inserted into SlpA without disrupting the lattice structure ([@B37]). Therefore, alternative methods exploiting auxiliary proteins associated with the S-layer are now being investigated for the display and delivery of larger antigens, as seen in Slp-mediated anchoring studies (see "The self-assembling and anchoring domains of the Slp"), but at frequencies more akin to direct integration.

S-Layer Associated Proteins
===========================

The *Lactobacillus* S-layer, once thought to be solely composed of repeating monomeric Slp subunits, is actually far more complex ([@B30], [@B31]). It is now widely accepted that S-layers can act as scaffolds for the external display of numerous auxiliary proteins, termed S-layer associated proteins (SLAPs), which can confer additional physiological functionalities ([@B30], [@B31], [@B33]; [@B28]; [@B32]; [@B14]). Recently, the SLAP profile of *L. acidophilus* NCFM was quantified via multiplexing mass spectrometry ([@B41]). Although results revealed significant growth stage-dependent alterations, they also highlighted several proteins with consistent high expression in both logarithmic and stationary growth phases ([@B41]). The surface location and abundance of these proteins make them excellent targets for biotherapeutic delivery. Unlike Slp integrants, SLAP fusions are theoretically less limited in epitope size as they are not prone to S-layer array disruption (**Figure [1F](#F1){ref-type="fig"}**). Both the native SLAP promoter and secretion signal can be harnessed for this process with the intent to maintain high expression, secretion, and surface localization coupled with the display and delivery of a significantly larger and therefore more potent epitope.

Slp Engineering Platforms
=========================

Presently, the two most popular techniques for engineering LABs are the NICE (NIsin Controlled gene Expression) system in *L. lactis* and the pORI-based *upp* counterselective gene replacement system in *L. acidophilus.* There is also growing interest surrounding the use of CRISPR-Cas technology, though its application in bacterial genome editing remains relatively underrepresented ([@B68]; [@B26]).

The NICE System
---------------

The NICE system uses nisin to drive heterologous protein expression in *L. lactis* ([@B43]). Through the insertion of signal transduction genes from a nisin gene cluster into a nisin-negative *L. lactis* strain, NZ9000 was created ([@B44]). Subsequently, when a gene of interest is inserted downstream of the inducible *nisA* promoter, expression of that gene can be obtained by the addition of nisin to the culture medium ([@B54]). Since its conception, NICE has become one of the most successful and widely used expression systems in Gram-positive bacteria ([@B54]). Indeed, the NICE system was even employed for the production a number of the S-layer fusion proteins mentioned above ([@B27]; [@B83]) and to render the non-adhesive *L. lactis* NZ9000 adhesive via the addition of an *L. brevis* SlpA receptor-binding domain ([@B3]). The availability of an easily engineered, non-S-layer-forming organism, has greatly accelerated not only our understanding of the biological role of an S-layer but also how we can exploit it.

The pORI-Based *upp* System
---------------------------

The establishment of the pORI-based *upp* counterselective gene replacement system in S-layer-former *L. acidophilus* NCFM, first employed for the functional characterization of SlpX ([@B24]), has since become an invaluable tool for S-layer component engineering. The system uses a *upp*-encoded uracil phosphoribosyltransferase (UPRTase) as a counterselection marker to positively select for double crossover homologous recombination events. The method has been adapted for numerous Slp studies ranging from reporter integration ([@B21]), anchoring/adjuvant assessment ([@B36]), and targeted antigen delivery systems for disease protection ([@B37]; [@B60]). Similar counterselective systems have also been developed in non-S-layer-formers including *L. gasseri* ATCC 33323 ([@B69]) and *L. casei* ATCC 393 ([@B74]), but have yet to be harnessed for Slp analyses. In general, the technique remains a superior approach for characterizing the functional genetics of lactobacilli without the additional pressures required for plasmid maintenance.

CRISPR
------

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) together with CRISPR-associated (Cas) proteins, form the prokaryotic adaptive immune system which provides DNA-encoded, RNA-guided, sequence-specific protection against viral invaders ([@B6]). The current classification system uses two broad classes consisting of six major types (I--VI) which can be allocated into approximately 30 subtypes ([@B40]). The simplest of these is the Type II system which relies on the activity of a singular Cas9 endonuclease and has gained immense popularity for its ability to be repurposed for genome editing ([@B19]; [@B6]; [@B40]). Depending on the organism, this can be done via harnessing of the endogenous system or supplying an exogenous Cas9:single guide RNA (sgRNA) complex. To date, no CRISPR-based genome editing has been performed in S-layer-forming lactobacilli, but it has been conducted in *L. casei* ([@B75]) and *L. lactis* ([@B8]), frequent hosts for recombinant Slp investigative research. Nevertheless, the development and delivery of a functional CRISPR-Cas9 plasmid remains a critical need, particularly in organisms such as *L. acidophilus* NCFM (depicted in **Figure [2A](#F2){ref-type="fig"}**), which does not possess an active CRISPR system ([@B20]), but has proven to be hugely impactful in both probiotic and Slp research.

![Proposed strategies for CRISPR-based genome editing in relevant S-layer-forming lactobacilli. **(A)** Antigen integration into *L. acidophilus* SlpA via an exogenous Type II system employing a Cas9 nickase variant which introduces a guide RNA-targeted single-stranded break. Unlike wild-type Cas9 which generates blunt double-stranded breaks (DSB), nickases cut only one strand of the DNA, permitting genome editing in bacteria deficient in DSB repair ([@B18]; [@B75]). **(B)** Antigen integration into *L. crispatus* CbsA using the endogenous Type I system which consists of the CRISPR-associated complex for antiviral defense (Cascade) and the signature Cas3 nuclease ([@B5]).](fmicb-09-02264-g002){#F2}

Despite the popularity of Type II engineering, Type I systems have been harnessed for genome editing in *Clostridium* and archaea ([@B62]; [@B17]) and transcriptional regulation in *E. coli* ([@B50]). S-layer formers, *L. crispatus*, and *L. helveticus*, frequently possess Type I systems ([@B20]) and are also of interest for vaccine delivery. *L. crispatus* is a natural inhabitant of the human vaginal tract ([@B46]), rendering it suitable for delivery of antigens targeting sexually transmitted diseases, such as HIV, while *L. helveticus* is predominately associated with dairy ([@B77]), which could be advantageous when considering modes of delivery and stability of the vaccine. A proposed strategy for Type I genome editing in *L. crispatus* is illustrated in **Figure [2B](#F2){ref-type="fig"}**. Harnessing of the endogenous system or delivery of a functional exogenous system both possess the potential to be powerful tools for advancing Slp-mediated biotherapeutic research.

The NICE and pORI-based *upp* systems have both proven effective for S-layer-mediated biotherapeutic delivery; however, next-generation genome editing tools, such as CRISPR-Cas, hold tremendous potential for bacterial engineering overall ([@B68]; [@B26]). Many S-layer-forming lactobacilli possess endogenous CRISPR systems, making them promising candidates for future S-layer engineering studies. Alternatively, delivery of a functional CRISPR to strains devoid of a system, will also greatly accelerate the pace at which recombinant organisms can be generated. Ironically, despite CRISPR originating as the bacterial adaptive immune system, CRISPR-based bacterial genome editing still remains relatively underexploited, though recent studies have provided valuable insights for its widespread future implementation ([@B68]).

Future Directions
=================

The Slp is a multi-faceted engineering target with both biotherapeutic and biotechnological applications ([@B71]). However, within the *Lactobacillus* genus, harnessing of this protein remains early in its development ([@B4]; [@B29]); nonetheless, the research highlighted above (summarized in **Table [1](#T1){ref-type="table"}**) advocates for its continued pursuit. The *slp* promoter and signal peptide are undoubtedly adept at driving robust expression and secretion of target proteins, while the structural domains have successfully displayed foreign epitopes and improved the adhesive capacity of host cells. More complex and novel display strategies, such as direct integration into the Slp or SLAP fusions, are innovative approaches for cell surface presentation that also exploit the inherent properties of S-layer-forming lactobacilli. In general, eliciting consistent immune responses via the mucosal route of administration is hindered by rapid elimination or inability to make contact with M cells and other mucosal tissues involved in antigen uptake and processing ([@B61]). Thus the ability of recombinant LABs, and the S-layer in particular, to promote antigen uptake and stimulate the adaptive immune response is highly desirable ([@B42]).

###### 

S-layer protein applications in recombinant protein expression systems and biotherapeutic delivery platforms.

  S-layer-forming lactobacilli   Slp          Slp Component                            Host                                                                                                   Antigen/Reporter                                                                                   Results                                                                                                                                                             Reference
  ------------------------------ ------------ ---------------------------------------- ------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------
  *L. acidophilus*               SlpA; SlpB   Promoter                                 *L. casei*                                                                                             CAT                                                                                                Evaluated *slpA* and *slpB* promoters; only *slpA* remained active under all tested growth conditions                                                               [@B13]
                                 SlpA         Promoter                                 *L. lactis; L. reuteri* chicken crop isolates                                                          eGFP                                                                                               The *slpA* promoter was highly efficient in *L. lactis* but nearly inactive in *L. reuteri* isolates                                                                [@B49]
                                 SlpA         Promoter                                 *L. casei; L. paracasei; L. plantarum; L. lactic; L. helveticus; L. acidophilus; L. lactis; E. coli*   GFP                                                                                                Plasmids encoding *slpA* promoter exhibited distinct properties based on host and growth phase                                                                      [@B16]
                                 SlpA         Promoter                                 *L. acidophilus*                                                                                       GusA                                                                                               The *slpA*-driven GusA activity increased three logs in comparison to the *gusA*-negative parent                                                                    [@B21]
                                 SlpA         Secretion                                *L. acidophilus*                                                                                       *B. anthracis* protective antigen (PA); *C. botulinum* Serotype A neurotoxin heavy-chain antigen   The SlpA signal sequence generated stable and robust secretion of the *C. botulinum* antigen                                                                        [@B60]
                                 SlpA         Secretion                                *L. acidophilus*                                                                                       *C. botulinum* Serotype A neurotoxin heavy-chain antigen                                           Recombinant organism was unable to confer complete protection against an experimental botulism challenge                                                            [@B64]
                                 SlpA         Integration                              *L. casei*                                                                                             GFP                                                                                                Generated a food-grade SlpA-based cell surface display vector and verified gastrointestinal stability *in vitro*                                                    [@B63]
                                 SlpA         Integration                              *L. acidophilus*                                                                                       HIV-1 membrane proximal external region (MPER)                                                     Delivery of MPER peptide via direct integration into SlpA stimulated antigen-specific antibody production in both serum and mucosal secretions of vaccinated mice   [@B37]
  *L. brevis*                    SlpA         Promoter                                 *L. lactis; L. plantarum; L. gasseri*                                                                  GusA; Luc; PepN                                                                                    The *slpA* promoter was recognized in all strains but especially *L. lactis* and *L. plantarum*                                                                     [@B34]
                                 SlpA         Promoter                                 *L. casei*                                                                                             Mouse IL-10                                                                                        The *slpA* promoter yielded high levels of IL-10 but was sensitive to low pH                                                                                        [@B35]
                                 SlpA         Promoter; secretion                      *L. lactis; L. brevis; L. plantarum; L. gasseri; L. casei*                                             *E. coli* β-lactamase (Bla)                                                                        Bla was expressed in all hosts, but most efficiently in *L. lactis* and *L. brevis*; production was restricted to exponential growth phase                          [@B67]
                                 SlpA         Secretion                                *L. lactis*                                                                                            *E. coli* F18 fimbrial adhesion protein (FedF)                                                     The SlpA signal sequence increased FedF secretion efficiency four to sixfold in comparison to the lactococcal Usp45 signal sequence                                 [@B47]
                                 SlpA         Secretion                                *L. lactis*                                                                                            Human interferon alpha 2b (hIFNα-2b)                                                               SlpA signal sequence increased hIFNα-2b secretion efficiency threefold in comparison to the lactococcal Usp45 signal sequence                                       [@B82]
                                 SlpA         Secretion; structural domain             *L. lactis*                                                                                            None                                                                                               Surface expression of SlpA receptor-binding domain increased adherence to Intestine 407 cells                                                                       [@B3]
                                 SlpA         Integration                              *L. brevis*                                                                                            Poliovirus VP1 epitope; c-Myc epitope                                                              Directly inserted epitopes into SlpA without disrupting array formation                                                                                             [@B2]
  *L. crispatus*                 LbsA         Promoter; secretion, structural domain   *Lactobacillus* chicken isolates                                                                       GFP                                                                                                Achieved expression, secretion and surface presentation of GFP                                                                                                      [@B58]
                                 LcsB         Structural domain                        *L. lactis*                                                                                            GFP                                                                                                Achieved surface presentation of GFP                                                                                                                                [@B27]
                                 LcsB         Structural domain                        *L. lactis*                                                                                            Carcinoembryonic antigen (CEA)                                                                     LcsB-mediated display of CEA stimulated higher levels of antigen-specific secretory IgA and a higher spleen index when fed to mice                                  [@B83]
                                 CbsA         Structural domain                        *L. casei*                                                                                             None                                                                                               Recombinant *L. casei* expressing CbsA was able to bind immobilized collagens                                                                                       [@B51]
                                 CbsA         Structural domain                        *L. casei*                                                                                             None                                                                                               Recombinant expression of CbsA domains enabled adhesion to laminin and collagen                                                                                     [@B1]

Numerous studies have established vaccine platforms based on one or more components of the *Lactobacillus* Slp, however, there remains a disconnect between delivery and efficacy. Despite extensive reviews touting the effectiveness of the LAB-based vaccines *in vivo* ([@B80]; [@B45]), few S-layer-based delivery frameworks have moved into animal models. Although successful secretion and/or surface display of the reporter/antigen is regularly achieved, only three of the recombinant organisms presented above were tested in mice ([@B37]; [@B83]; [@B64]), whereas the remainder were more focused on establishing that antigen production/display was even possible. Thus, an important step moving forward will be connecting the delivery of these antigens with an actual vaccination event, therefore surpassing proof of concept studies and ultimately demonstrating disease protection.
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